期刊文献+

血清铁蛋白对非酒精性脂肪肝患者早期肝纤维化的诊断价值 被引量:8

Clinical value of serum ferritin in diagnosis for hepatic fibrosis in patients with nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的研究血清铁蛋白(SF)对非酒精性脂肪肝(NAFLD)患者早期肝纤维化的诊断价值。方法随机选取104例NAFLD患者和60例健康人进行血清学、肝脏B超和SF检查。NAFLD患者行肝脏活组织检查。分析并评价SF对NAFLD患者早期肝纤维化的诊断价值。结果 NAFLD患者的丙氨酸氨基转移酶(ALT)、γ-谷氨酰转移酶(GGT)、总胆固醇(TC)、三酰甘油(TG)、透明质酸(HA)、层黏连蛋白(LN)、Ⅲ型前胶原氨基端肽(PⅢNP)、Ⅳ型胶原(CⅣ)、SF均高于健康对照组,差异有统计学意义(P<0.05)。0期肝纤维化患者的HA、CⅣ和SF小于早期患者,差异有统计学意义(P<0.05)。在早期患者中,相关性分析显示SF水平与HA、CⅣ呈正相关(rHA=0.44,rCⅣ=0.53,P<0.05)。ROC曲线发现SF对早期肝纤维化患者的诊断曲线下面积为0.688(P=0.005),当SF为93μg/L时,诊断的灵敏度为73%,特异性为67%。结论血清SF的升高能够反映NAFLD患者早期肝纤维化的变化,有望成为NAFLD早期肝纤维化的血清学辅助诊断指标。 Objective To evaluate the clinical value of serum ferritin(SF)in diagnosis for hepatic fibrosis in patients with nonalcoholic fatty liver disease(NAFLD).Methods One hundred and four NAFLD patients and sixty healthy controls were enrolled in this study.Serum routine test,hepatic ultrasonography and serum ferritin for all participants were assessed and liver biopsy were performed for NAFLD patients.Results The levels of alanine aminotransferase(ALT),gamma glutamine transferase(GGT),total cholesterol(TC),triacylglycerol(TG),hyaluronic acid(HA),laminin(LN),ProcollagenⅢ N-terminal peptide(PⅢNP),Collagen TypeⅣ(CⅣ)and SF in NAFLD patients were significantly higher than those of healthy controls(P〈0.05).The levels of HA,CⅣ and SF in fibrosis stage 0 patients were lower than the early stage patients(P〈0.05).SF was positive correlated with HA andCⅣ by Spearman analysis(rHA=0.44,rCⅣ=0.53,P〈0.05).The area under curve(AUC)of receiver operating characteristic(ROC)of SF was 0.688.When the SF level was 93μg/L,the sensitivity and specificity of SF were 73% and 67% respectively.Conclusion Serum levels of ferritin is positively correlated with the severity of liver fibrosis,which would be a promising biomarker for early fibrosis patients with NAFLD.
作者 黄越前
出处 《检验医学与临床》 CAS 2015年第10期1383-1385,共3页 Laboratory Medicine and Clinic
关键词 非酒精性脂肪肝 血清铁蛋白 肝纤维化 nonalcoholic fatty liver disease serum ferritin hepatic fibrosis
  • 相关文献

参考文献14

  • 1Fan JG, Farrell GC. Epidemiology of non alcoholic fatty liver disease in China[J]. J Hepatolo, 2009,50 ( 1 ) : 204 -210.
  • 2李杰,邹俊,陈茂伟.肝纤维化及肝硬化诊断方法的研究进展[J].山东医药,2011,51(45):113-114. 被引量:30
  • 3Farahvash MJ, Janney CG, Neuschwandertetri BA, et al Nonalcoholic steatoholic-an expanded clinical entity[J] Hepatolo, 1993,18(4) : A174.
  • 4Angulo P,Keach JC, Batts KP, et al. Independent predic tors of liver fibrosis in patients with nonalcoholic steato hepatitis[J]. Hepatolo,1999,30(4) :406.
  • 5范建高.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].现代医药卫生,2011,27(5):641-644. 被引量:121
  • 6American Gastroenterological Association. American gas- troenterological association medical position statement: nonalcoholic fatty liver disease[J]. Gastroenterol, 2002, 123(1) :1702-1704.
  • 7Farrell GC, Chitturi S, Lat GK, et al. Guidelines for the assessmentand management of non-alcoholic fatty liver disease in the Asia-Pacificregion: executive summary[J]. J Gastroenterol Hepatol, 2007,22(1) : 775-777.
  • 8Allegra CJ, Jessup JM, Somerfield MR, et al. American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with meta static colorectal carcinoma to predict response to Anti-Ep- idermal growth factor receptor monoclonal antibody ther- apy[J]. J Clin Oncol, 2009,27 (12) : 2091-2096.
  • 9Sanyl A. AGA Technical review on alcoholic fatty liver disease[J]. Gastroenterolo,2002,123(5) :1705- 1725.
  • 10刘君,陈娜.肝纤维化血清学指标的临床意义[J].检验医学与临床,2012,9(3):320-320. 被引量:14

二级参考文献24

共引文献182

同被引文献85

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部